Aadi Bioscience Inc

-0.04 (-0.32%)
7:15:32 PM EDT: $13.20 +0.62 (+4.93%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)306.88M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$4.65 Million
Adjusted EPS-$0.71
See more estimates
10-Day MA$12.71
50-Day MA$12.84
200-Day MA$13.39
See more pivots

Aadi Bioscience Inc Stock, NASDAQ:AADI

17383 Sunset Boulevard, Suite A250, Los Angeles, California 90272
United States of America
Phone: +1.424.473.8055
Number of Employees: 39


Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancers patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai on November 2007 and is headquartered in Los Angeles, CA.